KEY FEATURES
| Full Name | Annexin A2 |
|---|---|
| Synonym | ANX-A2; ANX2L4; CAL1H; LIP2; LPC2; LPC2D; P36; PAP-IV; Protein I; Chromobindin-8; Calpactin-1 heavy chain; Lipocortin II; Placental anticoagulant protein IV |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human ANXA2 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ANXA2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ANXA2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ANXA2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ANXA2. You can calculate the concentration of Human ANXA2 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ANXA2 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.48 | 1.04 | 4.6 | 0.47 | 1.02 | 4.32 |
| Standard deviation | 0.03 | 0.05 | 0.24 | 0.03 | 0.05 | 0.13 |
| CV(%) | 5.45 | 4.59 | 5.17 | 6.34 | 4.86 | 3.09 |
RECOVERY
The recovery of Human ANXA2 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-100 | 93 |
| EDTA plasma (n=8) | 94-107 | 101 |
| Cell culture media (n=8) | 87-101 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ANXA2 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with ANXA2 ELISA Kits
| S100A10 ELISA Kit | publications with ANXA2 and S100A10 |
| SRC ELISA Kit | publications with ANXA2 and SRC |
| S100A6 ELISA Kit | publications with ANXA2 and S100A6 |
| PLG ELISA Kit | publications with ANXA2 and PLG |
| S100A4 ELISA Kit | publications with ANXA2 and S100A4 |
| PLAT ELISA Kit | publications with ANXA2 and PLAT |
| CDC42 ELISA Kit | publications with ANXA2 and CDC42 |
| GRB2 ELISA Kit | publications with ANXA2 and GRB2 |
| DYSF ELISA Kit | publications with ANXA2 and DYSF |
| CTSB ELISA Kit | publications with ANXA2 and CTSB |
Pathways associated with ANXA2 ELISA Kit
| Prostaglandin Synthesis And Regulation Pathway | Prostaglandin Synthesis And Regulation Pathway |
Diseases associated with ANXA2 ELISA Kit
| Neoplasms | publications with ANXA2 and Neoplasms |
| Carcinoma | publications with ANXA2 and Carcinoma |
| Adenocarcinoma | publications with ANXA2 and Adenocarcinoma |
| Cardiovascular Diseases | publications with ANXA2 and Cardiovascular Diseases |
| Inflammation | publications with ANXA2 and Inflammation |
| Liver Diseases | publications with ANXA2 and Liver Diseases |
| Disease Models, Animal | publications with ANXA2 and Disease Models, Animal |
| Neoplasm Metastasis | publications with ANXA2 and Neoplasm Metastasis |
| Liver Neoplasms | publications with ANXA2 and Liver Neoplasms |
| Nervous System Diseases | publications with ANXA2 and Nervous System Diseases |
Organs/Tissues associated with ANXA2 ELISA Kit
| Blood | publications with ANXA2 and Blood |
| Bone | publications with ANXA2 and Bone |
| Vascular | publications with ANXA2 and Vascular |
| Liver | publications with ANXA2 and Liver |
| Lung | publications with ANXA2 and Lung |
| Bone Marrow | publications with ANXA2 and Bone Marrow |
| Prostate | publications with ANXA2 and Prostate |
| Connective Tissue | publications with ANXA2 and Connective Tissue |
| Brain | publications with ANXA2 and Brain |
| Kidney | publications with ANXA2 and Kidney |